Scheme & Guidelines
| Title | Download | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Notice for Inviting 3rd Round of Applications (Last Date Extend 30/04/2022) | |||||||||||||||
| Notice for Inviting 3rd Round of Applications (Last Date Extend) | |||||||||||||||
| Notice for Inviting 3rd Round of Applications | |||||||||||||||
| Extension Notice | |||||||||||||||
| Revised notice for re-invitation of application -
Inclusion of new product - Ofloxacin Inclusion of new product - Erythromycin Thiocynate (TIOC) Inclusion of new product - CDA and increase in capacity of eligible product - Artesunate |
|||||||||||||||
| Notice for Inviting 2nd Round of Applications | |||||||||||||||
| Scheme Notification | |||||||||||||||
| Guidelines | |||||||||||||||
| Presentation | |||||||||||||||
| FAQ | |||||||||||||||
| Banck A/C Details for Fee Payment |
|
||||||||||||||
| Contact Email |
|